AVALON GLOBOCARE CORP (AVCO) Stock Price, Quote, News and Overview
NASDAQ:AVCO - Nasdaq - US05344R1041 - Common Stock - Currency: USD
AVCO Quote, Performance and Key Statistics
0.5259
-0.1 (-16.52%)
The current stock price of AVCO is 0.5259 USD. In the past month the price increased by 4.7%. In the past year, price decreased by -49.43%.
AVCO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LB | LANDBRIDGE CO LLC-A | N/A | 4.99B | ||
| VTMX | CORP INMOBILIARIA VESTA-ADR | N/A | 2.13B | ||
| KW | KENNEDY-WILSON HOLDINGS INC | N/A | 1.22B | ||
| IRS | IRSA -SP ADR | N/A | 1.01B | ||
| MRNO | MURANO GLOBAL INVESTMENTS PL | N/A | 913.30M | ||
| FRPH | FRP HOLDINGS INC | 55.91 | 585.17M | ||
| LPA | LOGISTIC PROPERTIES OF THE A | N/A | 310.69M | ||
| SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 300.72M | ||
| TCI | TRANSCONTINENTAL REALTY INV | 75.27 | 240.62M | ||
| OZ | BELPOINTE PREP LLC | N/A | 239.63M | ||
| ARL | AMERICAN REALTY INVESTORS IN | N/A | 223.84M | ||
| SRG | SERITAGE GROWTH PROP- A | N/A | 216.64M |
Related stock screener links
About AVCO
Company Profile
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. The company operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. The company also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.
Company Info
AVALON GLOBOCARE CORP
4400 ROUTE 9, SUITE 3100
Freehold NEW JERSEY 07728 US
CEO: David Jin
Employees: 5
Company Website: http://www.avalon-globocare.com/
Phone: 17327804400.0
AVALON GLOBOCARE CORP / AVCO FAQ
What is the stock price of AVALON GLOBOCARE CORP today?
The current stock price of AVCO is 0.5259 USD. The price decreased by -16.52% in the last trading session.
What is the ticker symbol for AVALON GLOBOCARE CORP stock?
The exchange symbol of AVALON GLOBOCARE CORP is AVCO and it is listed on the Nasdaq exchange.
On which exchange is AVCO stock listed?
AVCO stock is listed on the Nasdaq exchange.
What is AVALON GLOBOCARE CORP worth?
AVALON GLOBOCARE CORP (AVCO) has a market capitalization of 46.82M USD. This makes AVCO a Nano Cap stock.
How many employees does AVALON GLOBOCARE CORP have?
AVALON GLOBOCARE CORP (AVCO) currently has 5 employees.
What are the support and resistance levels for AVALON GLOBOCARE CORP (AVCO) stock?
AVALON GLOBOCARE CORP (AVCO) has a support level at 0.52 and a resistance level at 0.56. Check the full technical report for a detailed analysis of AVCO support and resistance levels.
Should I buy AVALON GLOBOCARE CORP (AVCO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AVCO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AVCO, evaluating the profitability, health, valuation and growth aspects
- AVALON GLOBOCARE CORP (AVCO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AVALON GLOBOCARE CORP (AVCO) Sales and EPS estimates to see what analysts future expectations are.
- AVALON GLOBOCARE CORP (AVCO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AVALON GLOBOCARE CORP (AVCO) Insider and Institutional Ownership to learn about the owners and their transactions.
- AVALON GLOBOCARE CORP (AVCO) Stock Chart to make your own analysis
- AVALON GLOBOCARE CORP (AVCO) Latest news and press-releases to stay up to date.
Does AVALON GLOBOCARE CORP (AVCO) stock pay dividends?
AVCO does not pay a dividend.
When does AVALON GLOBOCARE CORP (AVCO) report earnings?
AVALON GLOBOCARE CORP (AVCO) will report earnings on 2022-11-22, after the market close.
What is the Price/Earnings (PE) ratio of AVALON GLOBOCARE CORP (AVCO)?
AVALON GLOBOCARE CORP (AVCO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.1).
AVCO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AVCO. When comparing the yearly performance of all stocks, AVCO is a bad performer in the overall market: 80.4% of all stocks are doing better.
AVCO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AVCO. AVCO may be in some trouble as it scores bad on both profitability and health.
AVCO Financial Highlights
Over the last trailing twelve months AVCO reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 27.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -600.07% | ||
| ROA | -82.31% | ||
| ROE | N/A | ||
| Debt/Equity | 14 |